The global Acupuncture Needles market was valued at USD 251.28 million in 2023, the base year, and is projected to reach USD 258.68 million in 2024 and USD 372.40 million by 2032, growing at a CAGR of 4.7% during the forecast period 2024–2032, according to Polaris Market Research. Key players include 3B Scientific GmbH, AcuMedic Ltd., asia-med GmbH, SEIRIN, Dana Medical Co., Suzhou Hualun Medical Appliance Co., Boen Healthcare Co., Wuxi Jiajian Medical Devices Co., and Suzhou Zhongjing Life Science Technology Co. Clinical demand and safety requirements underpin the outlook for medical device suppliers and healthcare providers.

Chronic Disease Burden Supports the Acupuncture Needles Market

A main driver of expansion is the rise in chronic diseases such as diabetes, obesity, and autoimmune conditions worldwide. According to the CDC, over 100.0 million Americans were living with diabetes or prediabetes in 2022, and the WHO reports that diabetes was directly responsible for roughly 1.6 million deaths worldwide in 2021. The WHO also estimated that 1.13 billion people had hypertension in 2021. Because acupuncture can treat and manage discomfort associated with chronic disease, demand for treatment is rising. A growing elderly population adds momentum, as older individuals are more susceptible to chronic diseases and chronic wounds and tend to prefer acupuncture, given the extremely low likelihood of side effects; acupuncture also provides relief for both bodily and mental pain. Asia Pacific led the market in 2022.

Pain Relief as a Growth Catalyst

The adoption of acupuncture for pain management is identified as a key driver of the Acupuncture Needles Market. The report notes that study results point to acupuncture as a potential treatment for chronic low back pain, with Western practitioners viewing acupuncture points as locations that activate connective tissue, muscles, and nerves, which is thought to increase the body’s natural painkillers. According to Practical Pain Management, up to 80% of Americans are predicted to experience back pain at some point, and the US healthcare system spends at least USD 50 billion annually on treating low back pain. A 2020 article in JAMA Oncology also reported that acupuncture and acupressure can help cancer patients feel less pain.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/acupuncture-needles-market

Hospital Demand and Surgical Recovery

The hospital segment held the highest revenue share in 2022. Segment development is driven by rising incidences of venous leg ulcers and diabetic foot ulcers, as well as an increase in surgical wounds brought on by a growing number of operations. Most surgical wounds are painful, deep, and relatively large, and acupuncture helps relieve physical and emotional suffering while aiding recovery from post-surgical trauma. It also helps reduce pain from SSI wounds. People with long-term diabetes frequently develop painful diabetic leg ulcers, and acupuncture therapy helps lessen their pain.

Product Segmentation and Safety Priorities

By product, the market is divided into disposable and non-disposable categories. Disposable needles accounted for the largest share in 2022 and are projected to expand at the fastest rate. Advantages include a low chance of patient-to-patient disease transmission and low cost, and most healthcare experts recommend disposable products because of accessibility and safety concerns. The report also lists the risk of infections caused by reusable needles as a market restraint, reinforcing procurement preferences for single-use products among hospitals and clinics.

Entrants and Regulatory Attention

Rising demand has encouraged local companies to enter the market. For instance, Ora Acupuncture, a new acupuncture facility, opened in the United States in March 2020. Regulators are also paying close attention: in January 2025, the FDA issued a warning letter to Robbins Instruments regarding marketing of its Dermo-Jet needle-free injector without appropriate regulatory clearance, highlighting strict enforcement toward acupuncture-related medical devices.

Conclusion

As the Acupuncture Needles Market advances from USD 258.68 million in 2024 toward USD 372.40 million by 2032, suppliers that prioritize infection control, clinical evidence, and regulatory compliance are positioned to serve growing hospital and clinic demand.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market